SEC Company Response from Dianthus Therapeutics, (DNTH) — Apr 29, 2019
Dianthus Therapeutics, Inc. /DE/ (DNTH) (CIK 0001690585)
Date: April 29, 2019 · CIK: 0001690585 · Accession: 0001193125-19-125363
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-231097
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Attention: Tonya K. Aldave Re: Magenta Therapeutics, Inc. Acceleration Request for Registration Statement on Form S-1 File No. 333-231097
Dear Ms. Aldave:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, (the “Underwriters”) hereby join in the request of Magenta Therapeutics, Inc. (the “Company”) for acceleration of the effective date of the above-referenced Registration Statement so that it becomes effective on May 1, 2019 at 4:00 p.m. Eastern Time or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Goodwin Procter LLP, may orally request by telephone call that such Registration Statement be declared effective.
Pursuant to Rule 460 under the Act, the Underwriters wish to advise you that there will be distributed to each Underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
We, the undersigned, as representatives of the several underwriters, have complied and will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Signature pages as follows]
Accepted: As of the date first written above
J.P. MORGAN SECURITIES LLC
GOLDMAN SACHS & CO. LLC
COWEN AND COMPANY, LLC
For themselves and on behalf of the several Underwriters listed in Schedule 1 hereto.
J.P. MORGAN SECURITIES LLC
By:
/s/ David Ke
Name: David Ke
Title: Executive Director
GOLDMAN SACHS & CO. LLC
By:
/s/ Elizabeth Wood
Name: Elizabeth Wood
Title: Managing Director
COWEN AND COMPANY, LLC
By:
/s/ George Milstein
Name: George Milstein
Title: Managing Director
[Signature Page to Acceleration Request]
Show Raw Text
CORRESP 1 filename1.htm CORRESP VIA EDGAR April 29, 2019 United States Securities and Exchange Commission Division of Corporation Finance Mail Stop 4561 100 F Street, N.E. Washington, D.C. 20549 Attention: Tonya K. Aldave Re: Magenta Therapeutics, Inc. Acceleration Request for Registration Statement on Form S-1 File No. 333-231097 Dear Ms. Aldave: In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, (the “Underwriters”) hereby join in the request of Magenta Therapeutics, Inc. (the “Company”) for acceleration of the effective date of the above-referenced Registration Statement so that it becomes effective on May 1, 2019 at 4:00 p.m. Eastern Time or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Goodwin Procter LLP, may orally request by telephone call that such Registration Statement be declared effective. Pursuant to Rule 460 under the Act, the Underwriters wish to advise you that there will be distributed to each Underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus. We, the undersigned, as representatives of the several underwriters, have complied and will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. [Signature pages as follows] Accepted: As of the date first written above J.P. MORGAN SECURITIES LLC GOLDMAN SACHS & CO. LLC COWEN AND COMPANY, LLC For themselves and on behalf of the several Underwriters listed in Schedule 1 hereto. J.P. MORGAN SECURITIES LLC By: /s/ David Ke Name: David Ke Title: Executive Director GOLDMAN SACHS & CO. LLC By: /s/ Elizabeth Wood Name: Elizabeth Wood Title: Managing Director COWEN AND COMPANY, LLC By: /s/ George Milstein Name: George Milstein Title: Managing Director [Signature Page to Acceleration Request]